Cancer Vaccines as Immunotherapy of Cancer (eBook, ePUB)

Redaktion: Buonaguro, Luigi; Burg, Sjoerd van der

• Format: ePub

Produktbeschreibung

Cancer Vaccines as Immunotherapy of Cancer provides extensive and state-of-the-art information about the meaning, relevance and limitation of therapeutic cancer vaccines. It covers all the aspects involved in the vaccine research and development (identification of optimal target antigens, formulations, delivery strategies, adjuvants among others) as well as their use in combination with other immunomodulatory approaches.

The book discusses topics such as identification of tumor associated and specific antigens, proteogenomic for identification of novel target tumor antigens, antigen-specific T cells, and Peptide and RNA based vaccines. Additionally, it covers oncolytic viruses for antigen delivery, cancer vaccine targeting viral antigens and combinatorial immunotherapy strategies.

Written by leading experts worldwide, this is a valuable resource for cancer researchers, oncologists and members of biomedical field who wants to understand in depth the recent findings in the field of cancer vaccines.

• Describes the state-of-the-art of the research and development of therapeutic cancer vaccines
• Presents detailed diagrams to help the reader understand the functionality of each type of vaccine discussed
• Encompasses recent findings in the field through chapters written by leading experts worldwide

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Produktdetails

• Verlag: Elsevier Science & Techn.
• Seitenzahl: 272
• Erscheinungstermin: 4. März 2022
• Englisch
• ISBN-13: 9780128239025
• Artikelnr.: 63559820

Autorenporträt

Luigi Buonaguro, PhD, is Head of Cancer Immunoregulation Unity at National Cancer Institute "Pascale? in Italy. His primary interest is the identification of novel target tumor antigens. In particular, Dr. Buonaguro is coordinating the development of a novel therapeutic cancer vaccine for liver cancer.

Inhaltsangabe

1. Introduction2. Identification of Tumor Associated Antigens3. Identification of Tumor Specific Antigens4. Proteogenomics for identification of novel target tumor antigens5. Antigen-specific T cells6. Tumor antigens for preventive strategies7. Peptide based vaccines8. RNA based vaccines9. Novel dendritic cells strategies10. Oncolytic viruses for antigen delivery11. Cancer vaccine targeting viral antigens12. Combinatorial immunotherapy strategies13. Conclusions